New Delhi, July 30 -- India's domestic pharmaceutical market is emerging as a bright spot for drugmakers, helping companies with a strong local franchise outpace peers exposed to the increasingly challenging US generics market.

Torrent Pharmaceuticals and Mankind Pharma both reported double-digit growth for the June quarter on Thursday, underscoring the resilience of India-focused businesses even as US-facing companies grapple with pricing pressure and weaker demand.

Torrent Pharma reported a 55% year-on-year increase in consolidated revenue from operations to Rs.4,921 crore, aided by the merger of JB Chemicals & Pharmaceuticals. Consolidated net profit rose 3% to Rs.566 crore, while Ebitda before exceptional items climbed 61% to Rs.1,6...